Gautam Patel Sells $453K of Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Jun 12, 2025
Open-Market Net Sale · SEC Form 4
−$452,537
Equity position changed by -3.2%
Equity Position
1.7M sh
1,760,476 → 1,704,050
Equity Change
-3.2%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Gautam Patel CIK 0001738054 |
Director
|
Gautam Patel at Amneal Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amneal Pharmaceuticals Inc
| 2026-08-12 | Award | — | View |
| 2026-05-08 | Exercise | — | View |
| 2025-06-18 | Sell | -$761,146 | View |
| 2025-05-08 | Exercise | — | View |
| 2025-05-06 | Sell | -$69,344 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | 2025-06-10 | S - Sale | 56,426 D | $8.02 | -$452,537 | 1,704,050 | Direct |
Footnotes (1)
- F1
- The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Show more
Related filings at Amneal Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
312
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $460M
- Tpg Gp A, Llc $213M
- Vanguard Portfolio Management Llc $210M
5%+ Holders · 13D/G
6 filers
-
Chintu Patel 9.4%
-
Chirag Patel 8.4%
-
Tushar Patel 17.6%
-
Black Rock, Inc. 7.6%
-
Patel Dipan 5.4%
Other insiders at Amneal Pharmaceuticals Inc
GET /v1/forms/4/0001628280-25-030958
API docs
View Original SEC Filing